Recent Posts
- Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix from The Malaysian Ministry of Health, its country’s equivalent to the U.S. FDA
- NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm
- Click on the link below to listen to the Generex Biotechnology Investor Call May 06, 2021
- Click on the link below to listen to the Generex Biotechnology Investor Call February 05, 2021
- Click on the link below to listen to the Generex Biotechnology Investor Call August 26, 2020
Archives
- July 2021 (1)
- June 2021 (1)
- May 2021 (11)
- April 2021 (3)
- March 2021 (1)
- February 2021 (2)
- January 2021 (1)
- December 2020 (1)